Gland Pharma, 543245, GLAND Share Price, Rating, Research, Analysis, Fundamental & Historical Data

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

24,145.05
34.60
1

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

21,603.71
1.36%
2.71

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

10 Years
5 Years
3 Years

15.41
16.56
8.78

EBITDA CAGR (%)

10 Years
5 Years
3 Years

16.11
6.89
-2.46

PAT CAGR (%)

10 Years
5 Years
3 Years

17.43
-0.01
-13.93

P:E (Median)

8 Years
5 Years
3 Years

-
-
36.87

P:BV (Average)

8 Years
5 Years
3 Years

-
-
3.64

EV:EBITDA (Average)

8 Years
5 Years
3 Years

-
-
18.40

Earnings Forecasts:

Description 2024 2025 2026 2027
Adj EPS 46.9 48.63 64.63 73.9
P/E Ratio 36.85 35.54 26.74 23.39
Revenue 5642 6120 6888 7614
EBITDA 1333 1363 1682 1996
Net Income 772 822 1108 1311
ROA 8 7.5 9.6 10.9
P/B Ratio 3.26 3.01 2.73 2.46
ROE 9.26 9.02 10.93 11.45
FCFF 718.31 346.53 469.38 844.67
FCFF Yield 2.64 1.27 1.73 3.1

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone

Description Dec 24 Dec 23 Var% Sep 24 Sep 23 Var% Jun 24 Jun 23 Var% Mar 24 Mar 23 Var%
Net Sales 1,010.78 1,097.86 -7.93% 1,062.99 1,010.67 5.18% 1,012.02 884.07 14.47% 1,174.83 785.42 49.58%
Expenses 619.64 728.37 -14.93% 699.19 663.57 5.37% 718.47 624.71 15.01% 742.00 616.27 20.40%
EBITDA 391.14 369.49 5.86% 363.80 347.10 4.81% 293.55 259.36 13.18% 432.83 169.15 155.89%
EBIDTM 38.70% 33.66% 34.22% 34.34% 29.01% 29.34% 36.84% 21.54%
Other Income 65.06 43.39 49.94% 57.80 41.11 40.60% 48.49 35.21 37.72% 46.95 38.94 20.57%
Interest 18.31 0.80 2,188.75% 0.17 0.91 -81.32% 0.91 1.60 -43.12% 4.53 2.18 107.80%
Depreciation 43.77 40.33 8.53% 41.61 40.24 3.40% 40.82 38.98 4.72% 42.56 37.54 13.37%
PBT 394.13 371.75 6.02% 379.82 347.06 9.44% 300.31 253.99 18.24% 432.69 111.91 286.64%
Tax 99.01 94.95 4.28% 98.11 89.54 9.57% 77.39 66.41 16.53% 111.28 32.70 240.31%
PAT 295.12 276.81 6.61% 281.71 257.53 9.39% 222.92 187.58 18.84% 321.41 79.21 305.77%
PATM 29.20% 25.21% 26.50% 25.48% 22.03% 21.22% 27.36% 10.08%
EPS 17.91 16.80 6.61% 17.09 15.63 9.34% 13.53 11.38 18.89% 19.50 4.81 305.41%

Description Dec 24 Dec 23 Var% Sep 24 Sep 23 Var% Jun 24 Jun 23 Var% Mar 24 Mar 23 Var%
Net Sales 1,384.05 1,545.15 -10.43% 1,405.83 1,373.42 2.36% 1,401.71 1,208.69 15.97% 1,537.45 785.01 95.85%
Expenses 1,024.10 1,188.76 -13.85% 1,108.78 1,049.35 5.66% 1,137.31 914.74 24.33% 1,178.80 616.59 91.18%
EBITDA 359.96 356.39 1.00% 297.06 324.08 -8.34% 264.40 293.95 -10.05% 358.65 168.42 112.95%
EBIDTM 26.01% 23.07% 21.13% 23.60% 18.86% 24.32% 23.33% 21.45%
Other Income 58.49 37.39 56.43% 59.66 53.15 12.25% 51.43 37.54 37.00% 42.15 38.94 8.24%
Interest 22.82 5.28 332.20% 6.11 6.05 0.99% 5.62 4.92 14.23% 9.96 2.20 352.73%
Depreciation 96.33 105.34 -8.55% 93.83 81.30 15.41% 91.96 65.31 40.81% 92.61 37.54 146.70%
PBT 299.30 283.16 5.70% 256.78 289.89 -11.42% 218.24 261.27 -16.47% 298.23 111.15 168.31%
Tax 94.61 91.30 3.63% 93.25 95.81 -2.67% 74.48 67.16 10.90% 105.81 32.47 225.87%
PAT 204.69 191.86 6.69% 163.53 194.08 -15.74% 143.76 194.10 -25.94% 192.42 78.68 144.56%
PATM 14.79% 12.42% 11.63% 14.13% 10.26% 16.06% 12.52% 10.02%
EPS 12.42 11.65 6.61% 9.93 11.78 -15.70% 8.73 11.79 -25.95% 11.68 4.78 144.35%

Annual Results

Standalone Figures in Rs. Crores /

Consolidated

Description TTM Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Net Sales 4,260.62 4,167.43 3,616.53 4,400.71 3,462.88 2,633.24 2,044.20 1,619.94 1,479.18 1,347.87 993.80 Net Sales Growth 12.77% 15.23% -17.82% 27.08% 31.51% 28.82% 26.19% 9.52% 9.74% 35.63% Cost Of Goods Sold 1,842.05 1,820.31 1,685.42 2,109.22 1,219.00 836.07 626.35 479.75 375.07 540.21 414.04 Gross Profit 2,418.57 2,347.12 1,931.10 2,291.49 2,243.88 1,797.18 1,417.85 1,140.18 1,104.11 807.66 579.75 GP Margin 56.77% 56.32% 53.40% 52.07% 64.80% 68.25% 69.36% 70.38% 74.64% 59.92% 58.34% Total Expenditure 2,779.30 2,758.65 2,597.98 2,890.07 2,160.61 1,677.77 1,337.89 1,084.84 854.19 845.63 677.60 Power & Fuel Cost - 117.19 124.84 95.05 74.58 78.50 74.03 60.35 49.24 46.96 42.72 % Of Sales - 2.81% 3.45% 2.16% 2.15% 2.98% 3.62% 3.73% 3.33% 3.48% 4.30% Employee Cost - 409.94 399.70 338.57 311.36 277.66 222.95 179.08 153.42 131.30 105.69 % Of Sales - 9.84% 11.05% 7.69% 8.99% 10.54% 10.91% 11.05% 10.37% 9.74% 10.63% Manufacturing Exp. - 218.95 194.21 179.85 436.84 391.88 337.81 269.23 217.13 72.95 62.42 % Of Sales - 5.25% 5.37% 4.09% 12.61% 14.88% 16.53% 16.62% 14.68% 5.41% 6.28% General & Admin Exp. - 109.27 119.02 93.79 58.62 57.77 47.00 78.76 42.74 32.91 30.74 % Of Sales - 2.62% 3.29% 2.13% 1.69% 2.19% 2.30% 4.86% 2.89% 2.44% 3.09% Selling & Distn. Exp. - 34.66 30.26 40.98 36.69 17.08 13.88 9.93 11.40 15.80 16.41 % Of Sales - 0.83% 0.84% 0.93% 1.06% 0.65% 0.68% 0.61% 0.77% 1.17% 1.65% Miscellaneous Exp. - 48.31 44.53 32.61 23.51 18.82 15.86 7.73 5.19 5.52 16.41 % Of Sales - 1.16% 1.23% 0.74% 0.68% 0.71% 0.78% 0.48% 0.35% 0.41% 0.56% EBITDA 1,481.32 1,408.78 1,018.55 1,510.64 1,302.27 955.47 706.31 535.10 624.99 502.24 316.20 EBITDA Margin 34.77% 33.80% 28.16% 34.33% 37.61% 36.28% 34.55% 33.03% 42.25% 37.26% 31.82% Other Income 218.30 166.67 240.46 223.94 134.78 139.17 85.56 48.79 33.56 36.76 29.65 Interest 23.92 7.84 7.41 5.24 3.41 7.18 3.56 4.13 6.39 16.42 16.69 Depreciation 168.76 162.11 146.74 110.30 98.78 94.59 81.96 78.21 74.15 63.46 56.72 PBT 1,506.95 1,405.50 1,104.86 1,619.04 1,334.85 992.87 706.36 501.56 578.01 459.11 272.43 Tax 385.79 362.17 272.58 406.89 337.85 220.01 234.45 180.45 164.28 145.51 63.16 Tax Rate 25.60% 25.77% 26.00% 25.13% 25.31% 22.16% 34.16% 35.98% 28.42% 31.69% 23.18% PAT 1,121.16 1,043.33 775.83 1,212.15 997.00 772.86 451.91 321.11 413.73 313.61 209.27 PAT before Minority Interest 1,121.16 1,043.33 775.83 1,212.15 997.00 772.86 451.91 321.11 413.73 313.61 209.27 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 26.31% 25.04% 21.45% 27.54% 28.79% 29.35% 22.11% 19.82% 27.97% 23.27% 21.06% PAT Growth 39.95% 34.48% -36.00% 21.58% 29.00% 71.02% 40.73% -22.39% 31.93% 49.86% EPS 68.03 63.31 47.08 73.55 60.50 46.90 27.42 19.48 25.10 19.03 12.70

Description TTM Mar 24 Mar 23 Mar 22 Mar 21 Mar 20
Net Sales 5,729.04 5,664.72 3,624.60 4,400.71 3,462.88 2,633.24 Net Sales Growth 16.63% 56.29% -17.64% 27.08% 31.51% Cost Of Goods Sold 2,201.81 2,173.09 1,685.42 2,109.11 1,219.00 836.07 Gross Profit 3,527.23 3,491.63 1,939.17 2,291.60 2,243.88 1,797.18 GP Margin 61.57% 61.64% 53.50% 52.07% 64.80% 68.25% Total Expenditure 4,448.99 4,331.65 2,599.84 2,890.56 2,160.65 1,677.77 Power & Fuel Cost - 229.99 124.84 95.05 74.58 78.50 % Of Sales - 4.06% 3.44% 2.16% 2.15% 2.98% Employee Cost - 1,256.89 403.26 338.57 311.36 277.66 % Of Sales - 22.19% 11.13% 7.69% 8.99% 10.54% Manufacturing Exp. - 327.19 194.23 179.85 436.84 391.88 % Of Sales - 5.78% 5.36% 4.09% 12.61% 14.88% General & Admin Exp. - 217.36 120.53 94.28 58.66 57.77 % Of Sales - 3.84% 3.33% 2.14% 1.69% 2.19% Selling & Distn. Exp. - 37.46 27.03 40.98 36.69 17.08 % Of Sales - 0.66% 0.75% 0.93% 1.06% 0.65% Miscellaneous Exp. - 89.66 44.53 32.72 23.51 18.82 % Of Sales - 1.58% 1.23% 0.74% 0.68% 0.71% EBITDA 1,280.07 1,333.07 1,024.76 1,510.15 1,302.23 955.47 EBITDA Margin 22.34% 23.53% 28.27% 34.32% 37.61% 36.28% Other Income 211.73 170.24 240.46 223.94 134.78 139.17 Interest 44.51 26.20 7.45 5.24 3.41 7.18 Depreciation 374.73 344.57 146.74 110.30 98.78 94.59 PBT 1,072.55 1,132.54 1,111.04 1,618.55 1,334.81 992.87 Tax 368.15 360.08 273.54 406.89 337.85 220.01 Tax Rate 34.32% 31.79% 25.94% 25.14% 25.31% 22.16% PAT 704.40 772.46 781.04 1,211.66 996.96 772.86 PAT before Minority Interest 704.40 772.46 781.04 1,211.66 996.96 772.86 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 12.30% 13.64% 21.55% 27.53% 28.79% 29.35% PAT Growth 6.93% -1.10% -35.54% 21.54% 29.00% EPS 42.74 46.87 47.39 73.52 60.50 46.90

Results Balance Sheet

Standalone Figures in Rs. Crores /

Consolidated

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Shareholder's Funds 8,995.29 7,953.30 7,158.23 5,903.28 3,646.24 2,862.11 2,410.42 2,089.81 1,677.07 1,394.19 Share Capital 16.47 16.47 16.43 16.36 15.49 15.49 15.49 15.49 15.49 15.67 Total Reserves 8,977.43 7,935.16 7,128.56 5,861.51 3,614.26 2,846.62 2,394.93 2,074.32 1,661.57 1,378.52 Non-Current Liabilities 131.60 89.68 93.97 80.31 80.78 127.79 139.37 130.55 121.95 119.76 Secured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 50.17 70.49 Unsecured Loans 2.55 3.26 3.82 3.93 4.07 4.96 5.49 5.92 6.37 6.67 Long Term Provisions 20.69 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Current Liabilities 414.20 730.20 581.94 512.46 359.02 532.68 378.55 253.38 287.29 244.18 Trade Payables 295.08 589.42 462.76 396.28 249.09 446.20 292.42 189.29 88.51 65.57 Other Current Liabilities 87.05 109.46 76.42 62.36 81.73 72.60 71.13 61.87 151.77 119.60 Short Term Borrowings 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 39.90 58.52 Short Term Provisions 32.07 31.32 42.75 53.82 28.20 13.88 15.01 2.23 7.12 0.50 Total Liabilities 9,541.09 8,773.18 7,834.14 6,496.05 4,086.04 3,522.58 2,928.34 2,473.74 2,086.31 1,758.13 Net Block 1,693.73 1,570.55 1,502.19 954.23 968.10 928.74 842.64 871.58 787.88 648.63 Gross Block 2,579.91 2,294.95 2,081.32 1,430.70 1,347.81 1,219.58 1,054.45 1,005.52 1,020.22 820.49 Accumulated Depreciation 886.18 724.41 579.13 476.46 379.71 290.83 211.81 133.94 232.34 171.86 Non Current Assets 4,969.76 1,884.84 1,989.70 1,372.99 1,239.75 1,165.13 1,077.36 1,065.60 1,014.41 902.65 Capital Work in Progress 120.00 177.22 190.75 337.81 188.47 123.16 198.88 161.15 202.10 192.08 Non Current Investment 2,385.74 8.16 8.16 0.55 0.00 0.00 0.00 0.00 0.17 0.17 Long Term Loans & Adv. 768.88 128.92 286.40 77.97 81.52 111.89 33.89 29.42 21.63 54.86 Other Non Current Assets 1.41 0.00 2.21 2.43 1.66 1.33 1.95 3.44 2.62 6.92 Current Assets 4,571.32 6,888.34 5,844.44 5,123.07 2,846.29 2,357.46 1,850.98 1,408.15 1,071.90 855.48 Current Investments 0.00 0.00 154.87 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Inventories 1,260.21 1,945.30 1,185.67 1,275.17 756.28 911.88 512.83 378.72 367.08 321.19 Sundry Debtors 1,171.40 862.84 1,074.81 670.97 601.78 506.10 475.21 417.87 350.69 169.31 Cash & Bank 1,598.55 3,767.00 3,085.80 3,005.20 1,325.19 753.35 670.84 533.08 273.23 315.63 Other Current Assets 541.17 90.83 96.75 84.12 163.03 186.13 192.10 78.48 80.91 49.35 Short Term Loans & Adv. 436.41 222.37 246.55 87.60 91.80 131.94 126.45 30.20 36.37 17.71 Net Current Assets 4,157.13 6,158.14 5,262.50 4,610.61 2,487.27 1,824.78 1,472.43 1,154.77 784.61 611.30 Total Assets 9,541.08 8,773.18 7,834.14 6,496.06 4,086.04 3,522.59 2,928.34 2,473.75 2,086.31 1,758.13

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20
Shareholder's Funds 8,723.84 7,958.72 7,157.62 5,903.24 3,646.24 Share Capital 16.47 16.47 16.43 16.36 15.49 Total Reserves 8,705.99 7,940.59 7,127.95 5,861.46 3,614.26 Non-Current Liabilities 488.60 89.68 93.97 80.31 80.78 Secured Loans 0.00 0.00 0.00 0.00 0.00 Unsecured Loans 106.54 3.26 3.82 3.93 4.07 Long Term Provisions 137.21 0.00 0.00 0.00 0.00 Current Liabilities 1,398.36 729.13 582.02 512.53 359.02 Trade Payables 862.69 587.35 462.85 396.35 249.09 Other Current Liabilities 425.13 109.48 76.42 62.36 81.73 Short Term Borrowings 0.00 0.00 0.00 0.00 0.00 Short Term Provisions 110.54 32.30 42.75 53.82 28.20 Total Liabilities 10,610.80 8,777.53 7,833.61 6,496.08 4,086.04 Net Block 3,946.75 1,570.55 1,502.19 954.23 968.10 Gross Block 5,011.68 2,294.95 2,081.32 1,430.70 1,347.81 Accumulated Depreciation 1,064.93 724.41 579.13 476.46 379.71 Non Current Assets 4,965.66 1,876.73 1,981.54 1,372.44 1,239.75 Capital Work in Progress 237.88 177.22 190.75 337.81 188.47 Non Current Investment 0.00 0.00 0.00 0.00 0.00 Long Term Loans & Adv. 773.93 128.96 286.40 77.97 81.52 Other Non Current Assets 7.09 0.00 2.21 2.43 1.66 Current Assets 5,645.15 6,900.81 5,852.08 5,123.64 2,846.29 Current Investments 0.00 0.00 154.87 0.00 0.00 Inventories 1,655.24 1,945.30 1,185.67 1,275.17 756.28 Sundry Debtors 1,558.69 871.39 1,074.81 670.97 601.78 Cash & Bank 1,839.43 3,770.68 3,093.44 3,005.75 1,325.19 Other Current Assets 591.80 91.00 96.75 84.15 163.03 Short Term Loans & Adv. 489.19 222.44 246.55 87.60 91.80 Net Current Assets 4,246.79 6,171.68 5,270.05 4,611.11 2,487.27 Total Assets 10,610.81 8,777.54 7,833.62 6,496.08 4,086.04

Cash Flow

Standalone Figures in Rs. Crores /

Consolidated

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Cash From Operating Activity 1,135.97 367.89 791.29 604.93 700.93 185.06 201.93 476.46 224.09 148.05 PBT 1,405.50 1,048.40 1,619.04 1,334.85 992.87 686.36 501.56 578.01 459.11 272.43 Adjustment 23.15 37.38 -28.19 17.30 32.15 76.12 50.94 70.69 68.72 56.67 Changes in Working Capital 23.38 -407.00 -393.05 -435.80 -79.94 -353.94 -193.43 -10.86 -187.17 -117.14 Cash after chg. in Working capital 1,452.02 678.78 1,197.80 916.36 945.07 408.53 359.07 637.85 340.66 211.96 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -316.05 -310.89 -406.51 -311.43 -244.14 -223.47 -157.14 -161.39 -116.56 -63.91 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -2,923.92 1,208.22 -1,010.23 -1,524.55 -766.08 -314.14 -358.84 -96.65 -11.91 -399.89 Net Fixed Assets -227.74 -200.10 -503.56 -232.23 -193.54 -89.41 -86.66 55.65 -209.75 -239.38 Net Investments -2,377.58 154.87 -162.48 -0.55 0.00 0.00 0.00 0.17 0.00 -0.12 Others -318.60 1,253.45 -344.19 -1,291.77 -572.54 -224.73 -272.18 -152.47 197.84 -160.39 Cash from Financing Activity -7.40 14.92 34.90 1,238.46 -6.87 -2.93 -3.59 -116.42 -92.90 333.48 Net Cash Inflow / Outflow -1,795.35 1,591.04 -184.04 318.84 -72.01 -132.01 -160.50 263.39 119.29 81.64 Opening Cash & Equivalents 1,905.22 311.18 491.92 169.50 236.40 372.84 533.08 273.23 157.81 76.04 Closing Cash & Equivalent 116.20 1,905.22 311.18 491.92 169.50 236.40 372.84 533.08 273.23 157.81

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20
Cash From Operating Activity 996.80 363.97 790.77 604.93 700.93 PBT 1,132.54 1,054.58 1,618.55 1,334.81 992.87 Adjustment 223.60 38.19 -28.27 17.30 32.15 Changes in Working Capital -53.20 -417.94 -393.01 -435.76 -79.94 Cash after chg. in Working capital 1,302.95 674.83 1,197.28 916.35 945.07 Interest Paid 0.00 0.00 0.00 0.00 0.00 Tax Paid -306.15 -310.87 -406.51 -311.43 -244.14 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -1,756.91 1,208.19 -1,002.62 -1,524.00 -766.08 Net Fixed Assets -227.74 -200.10 -503.56 -232.23 Net Investments -2,377.58 154.87 -162.48 -0.55 Others 848.41 1,253.42 -336.58 -1,291.22 Cash from Financing Activity -799.42 14.92 34.90 1,238.46 -6.87 Net Cash Inflow / Outflow -1,559.53 1,587.08 -176.95 319.39 -72.01 Opening Cash & Equivalents 1,908.89 318.82 492.46 169.50 236.40 Closing Cash & Equivalent 357.09 1,908.89 318.82 492.46 169.50

Financial Ratios

Standalone /

Consolidated

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Book Value (Rs.) 546.04 482.80 434.87 359.30 234.25 1847.12 1555.61 1348.70 1082.33 889.58 ROA 11.39% 9.34% 16.92% 18.84% 20.32% 14.01% 11.89% 18.15% 16.31% 13.75% ROE 12.31% 10.28% 18.62% 20.97% 23.81% 17.14% 14.27% 21.97% 20.42% 18.79% ROCE 16.67% 13.97% 24.86% 28.00% 30.68% 26.11% 22.41% 30.04% 28.35% 22.50% Fixed Asset Turnover 1.71 1.65 2.51 2.49 2.05 1.80 1.58 1.47 1.47 1.45 Receivable days 89.08 97.78 72.40 67.08 76.78 87.61 100.43 94.03 69.91 61.50 Inventory Days 140.38 158.00 102.05 107.06 115.61 127.19 100.26 91.25 92.53 114.35 Payable days 88.68 113.93 74.33 96.62 73.57 99.56 79.68 57.64 32.44 46.12 Cash Conversion Cycle 140.78 141.84 100.12 77.52 118.83 115.24 121.01 127.64 129.99 129.73 Total Debt/Equity 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.07 0.12 Interest Cover 180.20 142.41 309.98 392.34 139.24 193.80 122.59 91.43 28.97 17.32

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20
Book Value (Rs.) 529.56 483.12 434.84 359.30 234.25 ROA 7.97% 9.40% 16.91% 18.84% 18.91% ROE 9.26% 10.34% 18.61% 20.97% 21.29% ROCE 13.63% 14.04% 24.85% 28.00% 27.39% Fixed Asset Turnover 1.55 1.66 2.51 2.49 1.95 Receivable days 78.29 97.99 72.40 67.08 83.41 Inventory Days 116.00 157.65 102.05 107.06 104.83 Payable days 121.78 113.72 74.35 96.63 52.71 Cash Conversion Cycle 72.51 141.92 100.10 77.51 135.53 Total Debt/Equity 0.04 0.00 0.00 0.00 0.00 Interest Cover 44.23 142.61 309.77 392.33 139.24

Top Investors:

mirae asset large & midcap fund

hdfc mutual fund - hdfc mid-cap opportunities fund

nippon life india trustee ltd-a/c nippon india growth fund

icici prudential india opportunities fund

sbi large & midcap fund

government pension fund global

uti-flexi cap fund

Annual Reports:

News Update:

Gland Pharma receives USFDA’s approval for Acetaminophen Injection
3rd Apr 2025, 12:27 PM

This product is indicated for the management of mild to moderate pain in adult and pediatric patients 2 years and older
Read More
USFDA concludes pre-approval inspection at Visakhapatnam facility of Gland Pharma
25th Feb 2025, 16:27 PM

The said inspection was concluded with three form 483 observations
Read More
Gland Pharma reports 7% rise in Q3 consolidated net profit
3rd Feb 2025, 18:12 PM

Total consolidated income of the company decreased by 8.85% at Rs 1442.55 crore for Q3FY25
Read More
Gland Pharma - Quarterly Results
3rd Feb 2025, 17:22 PM

Read More
Gland Pharma gets EIR from USFDA for Pashamylaram facility
18th Jan 2025, 15:01 PM

USFDA has conducted inspection for Good Manufacturing Practices (GMP) at said facility between July 25, 2024 and August 02, 2024
Read More
Gland Pharma gets EIR from USFDA for Hyderabad facility
16th Jan 2025, 14:28 PM

USFDA has conducted inspection for Good Manufacturing Practices (GMP) at said facility between July 22, 2024 and July 25, 2024
Read More

Gland Pharma Ltd.

Pharmaceuticals & Drugs

BSE: 543245 | NSE: GLAND

Stock Summary

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

EBITDA CAGR (%)

PAT CAGR (%)

P:E (Median)

P:BV (Average)

EV:EBITDA (Average)

Earnings Forecasts:

Quarterly Results

Consolidated Figures in Rs. Crores /

Annual Results

Standalone Figures in Rs. Crores /

Results Balance Sheet

Standalone Figures in Rs. Crores /

Cash Flow

Standalone Figures in Rs. Crores /

Financial Ratios

Standalone /

Top Investors:

Annual Reports:

News Update:

Gland Pharma Ltd.

Pharmaceuticals & Drugs

BSE: 543245 | NSE: GLAND

Stock Summary

Shareholding Pattern

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

EBITDA CAGR (%)

PAT CAGR (%)

P:E (Median)

P:BV (Average)

EV:EBITDA (Average)

Earnings Forecasts:

Quarterly Results

Consolidated Figures in Rs. Crores /

Annual Results

Standalone Figures in Rs. Crores /

Results Balance Sheet

Standalone Figures in Rs. Crores /

Cash Flow

Standalone Figures in Rs. Crores /

Financial Ratios

Standalone /

Top Investors:

Annual Reports:

News Update: